Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

SHOCKING: Aridis pharmaceuticals | Mind Blowing Facts

Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday

Gainers

Benzinga · Sep 27, 2022

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · Jun 10, 2022

Recap: Aridis Pharmaceuticals Q1 Earnings

Aridis Pharmaceuticals (NASDAQ:ARDS) reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Benzinga · May 16, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Aridis Pharma COVID-19 Antibody Neutralizes Omicron Variant In Animal Study

Aridis Pharmaceuticals Inc's (NASDAQ: ARDS) fully human monoclonal antibodies (mAbs) in the

Benzinga · Feb 17, 2022

5 Short Squeeze Candidate To Watch: Aridis Pharmaceuticals Tops List, EVgo, Indonesia Energy Corp And More

Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.

Benzinga · Feb 14, 2022

Coverage From

Benzinga

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Omicron

2,996 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.